trifluoperazine has been researched along with Graves Ophthalmopathy in 1 studies
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Ji, QH | 1 |
| Ruge, F | 1 |
| Lane, C | 1 |
| Morris, D | 1 |
| Tee, AR | 1 |
| Dayan, CM | 1 |
| Ludgate, M | 1 |
1 other study available for trifluoperazine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
Topics: Adipogenesis; Adult; Female; Forkhead Transcription Factors; Glucuronosyltransferase; Graves Ophthal | 2016 |